Moderna shares slide after report of delay in COVID-19 vaccine trial
Moderna reiterated that its trial will begin this month, and that the company has worked with the National Institutes of Health for its study plan.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)ByREUTERS
